DENALI ADVISORS LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
DENALI ADVISORS LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,617
-54.7%
1,1000.0%0.00%
-60.0%
Q2 2023$27,841
-21.4%
1,1000.0%0.01%
-33.3%
Q1 2023$35,431
-16.6%
1,100
-52.2%
0.02%
-16.7%
Q4 2022$42,458
-65.2%
2,300
-48.9%
0.02%
-69.0%
Q3 2022$122,000
-19.7%
4,500
-59.1%
0.06%
+75.8%
Q2 2022$152,000
+19.7%
11,000
+69.2%
0.03%
-32.7%
Q1 2022$127,000
+19.8%
6,5000.0%0.05%
+22.5%
Q4 2021$106,0006,5000.04%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders